Tongqiao Huoxue Decoction inhibits ferroptosis by facilitating ACSL4 ubiquitination degradation for neuroprotection against cerebral ischemia-reperfusion injury

IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL
Zhijie Ou , Yanting Deng , Yan Wu , Yuanqi Wang , Yijing Zhao , Chang Liu , Zhuoyu Wang , Manhua Liu , Xin Hu , Li Fang , Juping Chen
{"title":"Tongqiao Huoxue Decoction inhibits ferroptosis by facilitating ACSL4 ubiquitination degradation for neuroprotection against cerebral ischemia-reperfusion injury","authors":"Zhijie Ou ,&nbsp;Yanting Deng ,&nbsp;Yan Wu ,&nbsp;Yuanqi Wang ,&nbsp;Yijing Zhao ,&nbsp;Chang Liu ,&nbsp;Zhuoyu Wang ,&nbsp;Manhua Liu ,&nbsp;Xin Hu ,&nbsp;Li Fang ,&nbsp;Juping Chen","doi":"10.1016/j.phymed.2024.155701","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Cerebral ischemia-reperfusion injury (CIRI) refers to brain tissue injury caused by the temporary interruption of cerebral blood flow ischemia followed by the restoration of reperfusion, which is the main cause of post-stroke brain injury. A traditional Chinese herbal preparation called Tongqiao Huoxue Decoction (TQHX) has shown promise in reducing CIRI in rats. However, the mechanism of this herbal preparation for CIRI remains unclear.</p></div><div><h3>Purpose</h3><p>This study aimed to evaluate the therapeutic effect of TQHX extract on rats with CIRI and to further explore the underlying mechanisms.</p></div><div><h3>Methods</h3><p>The active ingredients of TQHX extract were quantified by the high-performance liquid chromatography (HPLC) condition. We conducted thorough investigations to assess the effects of TQHX on CIRI and ferroptosis using oxygen-glucose deprivation/reperfusion (OGD/R)-treated PC12 cells as an in vitro model and transient middle cerebral artery occlusion (tMCAO) animals as an in vivo model. The neurological score assessment was performed to evaluate the neuroprotective effects of TQHX extract on tMCAO rats. Using histologic methods to study the extent of cerebral infarction, blood-brain barrier, and rat brain tissue. We examined the impact of TQHX on ferroptosis-related markers of Fe<sup>2+</sup>, superoxide dismutase (SOD), reactive oxygen species (ROS), and malondialdehyde (MDA) in the brain tissue. In addition, the expression of key proteins and markers of ferroptosis, as well as key factors associated with Acyl-CoA synthetase long-chain family member 4 (ACSL4) were detected by Western blot and quantitative real-time PCR (RT-qPCR).</p></div><div><h3>Results</h3><p>TQHX extract could decrease the Longa score and extent of cerebral infarction of tMCAO rats, which exerted the function of neuroprotection. Additionally, TQHX treatment efficiently decreased levels of MDA and ROS while increasing the expression of SOD and ferroptosis-related proteins including ferritin heavy chain 1 (FTH1) and glutathione peroxidase 4 (GPX4) at the transcription and translation level. Meanwhile, TQHX provided strong protection against oxidative stress and ferritin accumulation by increasing the ubiquitination and degradation of ACSL4. The injection of OE-ACSL4 reversed the effects of TQHX on neuroprotection and ferroptosis inhibition in PC12 cells. The injection of shACSL4 reversely validate the crucial role of ACSL4 in CIRI rat treatment.</p></div><div><h3>Conclusion</h3><p>This work shows that TQHX promotes the ubiquitination-mediated degradation of ACSL4, which improves oxidative stress and inhibits the beginning of ferroptosis in cells. TQHX provides a possible path for additional research in CIRI therapies, advancing translational investigations.</p></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"130 ","pages":"Article 155701"},"PeriodicalIF":8.3000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S094471132400360X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Cerebral ischemia-reperfusion injury (CIRI) refers to brain tissue injury caused by the temporary interruption of cerebral blood flow ischemia followed by the restoration of reperfusion, which is the main cause of post-stroke brain injury. A traditional Chinese herbal preparation called Tongqiao Huoxue Decoction (TQHX) has shown promise in reducing CIRI in rats. However, the mechanism of this herbal preparation for CIRI remains unclear.

Purpose

This study aimed to evaluate the therapeutic effect of TQHX extract on rats with CIRI and to further explore the underlying mechanisms.

Methods

The active ingredients of TQHX extract were quantified by the high-performance liquid chromatography (HPLC) condition. We conducted thorough investigations to assess the effects of TQHX on CIRI and ferroptosis using oxygen-glucose deprivation/reperfusion (OGD/R)-treated PC12 cells as an in vitro model and transient middle cerebral artery occlusion (tMCAO) animals as an in vivo model. The neurological score assessment was performed to evaluate the neuroprotective effects of TQHX extract on tMCAO rats. Using histologic methods to study the extent of cerebral infarction, blood-brain barrier, and rat brain tissue. We examined the impact of TQHX on ferroptosis-related markers of Fe2+, superoxide dismutase (SOD), reactive oxygen species (ROS), and malondialdehyde (MDA) in the brain tissue. In addition, the expression of key proteins and markers of ferroptosis, as well as key factors associated with Acyl-CoA synthetase long-chain family member 4 (ACSL4) were detected by Western blot and quantitative real-time PCR (RT-qPCR).

Results

TQHX extract could decrease the Longa score and extent of cerebral infarction of tMCAO rats, which exerted the function of neuroprotection. Additionally, TQHX treatment efficiently decreased levels of MDA and ROS while increasing the expression of SOD and ferroptosis-related proteins including ferritin heavy chain 1 (FTH1) and glutathione peroxidase 4 (GPX4) at the transcription and translation level. Meanwhile, TQHX provided strong protection against oxidative stress and ferritin accumulation by increasing the ubiquitination and degradation of ACSL4. The injection of OE-ACSL4 reversed the effects of TQHX on neuroprotection and ferroptosis inhibition in PC12 cells. The injection of shACSL4 reversely validate the crucial role of ACSL4 in CIRI rat treatment.

Conclusion

This work shows that TQHX promotes the ubiquitination-mediated degradation of ACSL4, which improves oxidative stress and inhibits the beginning of ferroptosis in cells. TQHX provides a possible path for additional research in CIRI therapies, advancing translational investigations.

Abstract Image

潼侨藿香正气水通过促进 ACSL4 泛素化降解来抑制铁变态反应,从而对脑缺血再灌注损伤起到神经保护作用
背景脑缺血再灌注损伤(CIRI)是指脑血流缺血暂时中断后再灌注恢复所引起的脑组织损伤,是中风后脑损伤的主要原因。一种名为 "潼桥藿香煎"(TQHX)的传统中药制剂有望减轻大鼠的 CIRI。本研究旨在评估潼侨藿香正气水提取物对中风后脑损伤大鼠的治疗效果,并进一步探讨其潜在机制。方法采用高效液相色谱法(HPLC)对潼侨藿香正气水提取物的有效成分进行定量。我们以氧-葡萄糖剥夺/再灌注(OGD/R)处理的 PC12 细胞为体外模型,以瞬时大脑中动脉闭塞(tMCAO)动物为体内模型,对 TQHX 对 CIRI 和铁突变的影响进行了深入研究。通过神经评分评估 TQHX 提取物对 tMCAO 大鼠的神经保护作用。使用组织学方法研究脑梗塞程度、血脑屏障和大鼠脑组织。我们研究了 TQHX 对脑组织中与铁氧化相关的标记物 Fe2+、超氧化物歧化酶(SOD)、活性氧(ROS)和丙二醛(MDA)的影响。结果TQHX提取物能降低tMCAO大鼠的Longa评分和脑梗死程度,发挥神经保护作用。此外,TQHX 还能有效降低 MDA 和 ROS 水平,同时在转录和翻译水平上增加 SOD 和铁蛋白重链 1(FTH1)、谷胱甘肽过氧化物酶 4(GPX4)等铁氧化相关蛋白的表达。同时,TQHX通过增加ACSL4的泛素化和降解,对氧化应激和铁蛋白积累提供了强有力的保护。注射 OE-ACSL4 逆转了 TQHX 对 PC12 细胞神经保护和铁蛋白沉积抑制的作用。结论这项研究表明,TQHX 可促进泛素化介导的 ACSL4 降解,从而改善细胞的氧化应激并抑制铁变态反应的开始。TQHX 为 CIRI 疗法的其他研究提供了可能的途径,推动了转化研究的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Phytomedicine
Phytomedicine 医学-药学
CiteScore
10.30
自引率
5.10%
发文量
670
审稿时长
91 days
期刊介绍: Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信